PubRank

Arnon Rosenthal

Author PubWeight™ 31.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 2009 3.46
2 Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation 2004 2.67
3 Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J Neurosci 2004 2.38
4 Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol Sci 2005 2.06
5 Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice. J Neurosci 2006 1.79
6 Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration. Neurobiol Dis 2004 1.73
7 The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons. Nat Neurosci 2003 1.66
8 Neurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the gene. Mol Cell Biol 2003 1.53
9 Molecular basis for catecholaminergic neuron diversity. Proc Natl Acad Sci U S A 2004 1.47
10 Gata2 specifies serotonergic neurons downstream of sonic hedgehog. Development 2004 1.34
11 Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain 2005 1.20
12 TrkB agonists ameliorate obesity and associated metabolic conditions in mice. Endocrinology 2007 1.16
13 Loss of Hspa9b in zebrafish recapitulates the ineffective hematopoiesis of the myelodysplastic syndrome. Blood 2005 1.16
14 Zinc finger protein too few controls the development of monoaminergic neurons. Nat Neurosci 2003 1.15
15 Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice. J Neuroinflammation 2006 0.97
16 Appetite enhancement and weight gain by peripheral administration of TrkB agonists in non-human primates. PLoS One 2008 0.92
17 C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropathol 2013 0.92
18 A direct role of the homeodomain proteins Phox2a/2b in noradrenaline neurotransmitter identity determination. J Neurochem 2002 0.91
19 Suppression of amyloid deposition leads to long-term reductions in Alzheimer's pathologies in Tg2576 mice. J Neurosci 2009 0.89
20 Deglycosylated anti-Abeta antibody dose-response effects on pathology and memory in APP transgenic mice. J Neuroimmune Pharmacol 2008 0.85
21 Molecular mechanisms controlling the development of dopaminergic neurons. Semin Cell Dev Biol 2003 0.84
22 Treatment with trkC agonist antibodies delays disease progression in neuromuscular degeneration (nmd) mice. Hum Mol Genet 2005 0.79
23 Chronological age impacts immunotherapy and monocyte uptake independent of amyloid load. J Neuroimmune Pharmacol 2011 0.75